What’s New!
When Large-Language-Models Make Sense: A Game Changer for Enterprises
At EDBI’s inaugural masterclass in collaboration with NVIDIA, we delved into the world of Large Language Models (LLM) and glimpsed into the opportunities and challenges in its landscape led by Dr. Ettikan K Karuppiah, director and technologist and Dr. Deb Goswani, head of developer programs - big data and analytics at NVIDIA.
A recipe for success: How to thrive in Southeast Asia alternative protein market
Singapore has taken bold steps in accelerating innovation in the agrifood landscape in the recent years. For instance, while global regulators grappled with how to regulate cell-based foods, Singapore Food Agency (SFA) broke the impasse by becoming the first to grant regulatory approval for cell-based meat in 2021.
Ambiq Achieves Milestone of Powering Over 200 Million IoT Devices
Austin, TX and Singapore, 13 June 2023 – Ambiq®, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in energy efficiency, achieved a key milestone of powering over 200 million IOT devices earlier this year.
When Large-Language-Models Make Sense: A Game Changer for Enterprises
At EDBI’s inaugural masterclass in collaboration with NVIDIA, we delved into the world of Large Language Models (LLM) and glimpsed into the opportunities and challenges in its landscape led by Dr. Ettikan K Karuppiah, director and technologist and Dr. Deb Goswani, head of developer programs - big data and analytics at NVIDIA.
- 13 Oct 2023
A recipe for success: How to thrive in Southeast Asia alternative protein market
Singapore has taken bold steps in accelerating innovation in the agrifood landscape in the recent years. For instance, while global regulators grappled with how to regulate cell-based foods, Singapore Food Agency (SFA) broke the impasse by becoming the first to grant regulatory approval for cell-based meat in 2021.
- 10 Jul 2023
Ambiq Achieves Milestone of Powering Over 200 Million IoT Devices
Austin, TX and Singapore, 13 June 2023 – Ambiq®, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in energy efficiency, achieved a key milestone of powering over 200 million IOT devices earlier this year.
- 13 Jun 2023
Could Singapore become the next global biotech hub?
Despite planting seeds for decades, Singapore has yet to blossom into a global hub for biotechs. A new wave of international biopharmas setting up shop in the country and an influx of sophisticated, global biotech investors could change that.
- 2 May 2023
EdgeQ Closes $75M Series-B Investment and Ramps to Customers’ Demand for Its Award-Winning 5G+AI Base Station-on-a-Chip for 5G Networks
Lattice Semiconductor CEO Jim Anderson Joins the Board of Directors as the Company Enters into Customer Deployments of Private 5G and Open RAN Networks
- 2 May 2023
Proxtera announces successful first close, of Series Seed round of funding with Ant Group, CerraCap Ventures, and EDBI
The funding will be used as working capital to further develop the company’s innovative digital cross-border trade and financial services enabled by trusted credentials.
- 30 Mar 2023
What to watch in the biomedical space over the next five years
The pandemic has brought the spotlight onto the healthcare and biomedical sectors, driving unprecedented enthusiasm in the relatively unknown field of mRNA innovations, and bolstering growth in digital health. Yet, the silver lining has dulled investors’ sentiments post-COVID. Increasingly, investors have become more cautious against macroeconomic headwinds, and many are expecting a correction in company valuations across all sectors.
- 23 Feb 2023
Senior management changes at EDBI
EDBI announces changes to management that will take effect from 1 February 2023.
- 28 Nov 2022
Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion
The latest round of funding was led by Patient Square Capital and included participation from EDBI, PS Capital, Alafi Capital, and NRW.BANK, as well as other existing investors.
- 24 Oct 2022
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors. Anzu Partners led the $14M financing round with participation from Amgen Ventures and EDBI.
- 20 Sep 2022
